These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9209216)

  • 41. [Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].
    Gangneux JP; Marty P
    Sante; 2001; 11(4):257-8. PubMed ID: 11861203
    [No Abstract]   [Full Text] [Related]  

  • 42. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
    Antinori S; Longhi E; Bestetti G; Piolini R; Acquaviva V; Foschi A; Trovati S; Parravicini C; Corbellino M; Meroni L
    Br J Dermatol; 2007 Nov; 157(5):1032-6. PubMed ID: 17854365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.
    Angarano G; Maggi P; Coppola SL; Cavaliere RL
    Eur J Clin Microbiol Infect Dis; 1998 May; 17(5):365-7. PubMed ID: 9721971
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana.
    Nacher M; Carme B; Sainte Marie D; Couppié P; Clyti E; Guibert P; Pradinaud R
    Ann Trop Med Parasitol; 2001 Jun; 95(4):331-6. PubMed ID: 11454242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
    Laguna F; Adrados M; Alvar J; Soriano V; Valencia ME; Moreno V; Polo R; Verdejo J; Jiménez MI; Martínez P; Martínez ML; González-Lahoz JM
    Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):898-903. PubMed ID: 9495670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 47. Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.
    Alsina-Gibert M; López-Lerma I; Martinez-Chamorro E; Herrero-Mateu C
    Arch Dermatol; 2006 Jun; 142(6):787-9. PubMed ID: 16785393
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis.
    Troya J; Casquero A; Muñiz G; Fernández-Guerrero ML; Górgolas M
    Parasitology; 2007 May; 134(Pt 5):621-4. PubMed ID: 17156583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].
    Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.
    Lopez Dupla M; Gil Aguado A; Lavilla Uriol P; Pintado Garcia V; Valencia Ortega E; Martinez Martinez P; Garcia-Puig J
    J Antimicrob Chemother; 1993 Oct; 32(4):657-9. PubMed ID: 8288512
    [No Abstract]   [Full Text] [Related]  

  • 51. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M; Stephenson K; Gauar S; Frenkel L
    Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
    [No Abstract]   [Full Text] [Related]  

  • 52. HIV-associated visceral leishmaniasis.
    Pintado V; López-Vélez R
    Clin Microbiol Infect; 2001 Jun; 7(6):291-300. PubMed ID: 11442562
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
    Amato V; Amato J; Nicodemo A; Uip D; Amato-Neto V; Duarte M
    Ann Dermatol Venereol; 1998 Aug; 125(8):492-5. PubMed ID: 9747313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
    Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secondary prophylaxis for Leishmania infection in an HIV-positive patient.
    Orlando G; Del Sorbo F; Corbellino M; Schiavini M; Cargnel A
    AIDS; 1998 Oct; 12(15):2086-7. PubMed ID: 9814886
    [No Abstract]   [Full Text] [Related]  

  • 56. A background and critical analysis of the treatment of pneumocystis carinii pneumonia (PCP) in HIV/AIDS.
    Mitchell B
    Aust Nurs J; 2007 Apr; 14(9):20-3. PubMed ID: 17441498
    [No Abstract]   [Full Text] [Related]  

  • 57. [Visceral leishmaniasis in patients infected by HIV. An AIDS diagnostic criteria?].
    Rousaud F
    Rev Clin Esp; 1993 May; 192(9):462. PubMed ID: 8516518
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy of short-course intramuscular pentamidine isethionate treatment on Old World localized cutaneous leishmaniasis in 2 patients.
    Jauréguiberry S; Graby G; Caumes E
    Clin Infect Dis; 2006 Jun; 42(12):1812-3. PubMed ID: 16705598
    [No Abstract]   [Full Text] [Related]  

  • 59. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maintenance itraconazole for visceral leishmaniasis in HIV infection.
    Lafeuillade A; Chaffanjon P; Delbeke E; Quilichini R
    Am J Med; 1992 Apr; 92(4):449. PubMed ID: 1313638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.